Company Filing History:
4 out of 14 
4 out of 293 
Years Active: 2021-2025
Title: Innovations by Shu Yi Shen in Cancer Detection
Introduction
Shu Yi Shen is a notable inventor based in Markham, Canada. He has made significant contributions to the field of cancer detection through innovative methodologies. With a total of 4 patents, his work focuses on advancing the understanding and classification of cancer through methylome analysis.
Latest Patents
Shu Yi Shen's latest patents include groundbreaking methods for cancer detection and classification using methylome analysis. One patent describes a method of capturing cell-free methylated DNA from a sample containing less than 100 mg of cell-free DNA. This method involves several steps, including library preparation for sequencing, adding methylated filler DNA, denaturing the sample, and capturing the cell-free methylated DNA using a selective binder. Another patent outlines a method for detecting DNA from cancer cells in a subject. This process includes providing a sample of cell-free DNA, preparing it for sequencing, and comparing the sequences to those from healthy and cancerous individuals to identify the presence of cancer cell DNA.
Career Highlights
Throughout his career, Shu Yi Shen has worked with esteemed organizations such as Sinai Health System and University Health Network. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in cancer research.
Collaborations
Shu Yi Shen has collaborated with notable colleagues, including Daniel Diniz De Carvalho and Rajat Singhania. These partnerships have further enriched his research and innovation efforts in cancer detection.
Conclusion
Shu Yi Shen's contributions to cancer detection through innovative methodologies highlight his role as a leading inventor in the field. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.